Home

SAiGENCI logo

SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and linking to clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.

Help make cancer history

100% of your gift will support leading-edge cancer research, which will lead to better outcomes for patients with cancer, and their families.

With your support, we can save lives.

Give now

Sign up to our mailing list

Keep up to date with how we are changing the future of cancer treatment. 

Register your details

Featured projects

From Biobank to breakthroughs

The Australian Lions Childhood Cancer Research Foundation (ALCCRF) has made a transformative impact on paediatric brain cancer research by donating $600,000 to a team at the South Australian immunoGENomics Cancer Institute (SAiGENCI).

Read more about From Biobank to breakthroughs

Movember and SAiGENCI partner on landmark database to drive improvements in prostate cancer care

Movember, the leading global men’s health charity, has partnered with the South Australian immunoGENomics Cancer Institute (SAiGENCI) at the University of Adelaide, to create a transformative database that will help researchers develop strategies for clinicians to personalise decisions about prostate cancer care.

Read more about Movember and SAiGENCI partner on landmark database to drive improvements in prostate cancer care

Leadership appointments

Professor Christopher Sweeney

Professor Christopher Sweeney is SAiGENCI's inaugural Director.

Read more

Professor Lisa Butler

Professor Lisa Butler is Program Lead for the Resistance Prevention program.  She also leads SAiGENCI’s Graduate Program for HDR and Honours students.

Read more

Professor Brendan Jenkins

Professor Brendan Jenkins is Program Lead for the Tumour Inflammation and Immunotherapy program.

Read more

Professor Lan Nguyen

Professor Lan Nguyen is Program Lead for the Computational Systems Oncology program.

Read more

Professor Jose Polo

Professor Jose Polo is Program Lead for Cancer Epigenetics in SAiGENCI, building the epigenetics capacity within the Institute.  Professor Polo has established the Adelaide Centre for Epigenetics (ACE). 

Read more

News

22

May

Fighting cancer from within

Lung cancer is the leading cause of cancer-related deaths in Australia, taking the lives of an estimated 8,900 people last year alone. 

22

May

Glenda's story

When Glenda was diagnosed with stage 4 non-small cell lung cancer in 2014 at just 57 years old, she was in shock.  “I had never smoked a day in my life,” Glenda said.

more...

Events

30

Jan

The Adelaide Cancer Seminar Series

The Adelaide Cancer Seminar Series are jointly organised by the South Australian immunoGENomics Cancer Institute (SAiGENCI), Centre for Cancer Biology (CCB) and the South Australian Health and Medical Research Institute (SAHMRI).  The aim of the seminar series is to forge links across the research community, foster collaborative links between the researchers within Australia and internationally and to showcase outstanding research being conducted around Australia by top scientists.

more...

Updates from Twitter

Follow us on Twitter for the latest from SAiGENCI.

SAiGENCI on Twitter